In this manuscript we investigated recombinase RAD51 for its genomic impact as well as its association with clinical outcome in solid tumors including esophageal adenocarcinoma (EAC) and colon and breast cancers. The gene discussed is RAD51; the disease is esophageal adenocarcinoma.